Science & Translation Gene and Cell Therapies: Shaping the National Strategy
The recently published National Strategy for Gene and Cell-Based Therapies is intended to link the players in this innovative field of medicine throughout Germany and to speed up the introduction of treatment approaches into clinical care. Four experts from Hamburg were involved in the development of the strategy. What is most important to them?
Science & Translation Stem cell medicine in the North: The report
When the experts meet in Hamburg in July for the most important global congress in stem cell research – the ISSCR Annual Meeting – many regional players from the Life Science Nord cluster will also be there. A guide to the region's major players in research and industry in the stem cell field.
Portrait AI and crystals: “We provide the blueprint for innovative drug design”
The start-up CrystalsFirst specializes in structural biological analyses of protein crystals for drug development. The team has been based at DESY in Hamburg-Bahrenfeld since 2022. In this interview, founder and CEO Serghei Glinca talks about the technology and the structural biology ecosystem in the North of Germany.
Networking|Portrait Our Chairwoman for Regulatory Affairs: Heike Wachenhausen
Heike Wachhausen has been our honorary chairwoman at Life Science Nord e.V. since autumn 2021. She is our trusted contact for all regulatory affairs issues.
By category
Business Nord Pharmaceutical Production in the North: An Overview
Northern Germany is home to renowned pharmaceutical manufacturers with a global reach. This region is a hub for key industry players involved in pharmaceutical production, ranging from innovative small and medium-sized enterprises to multinational corporations. There are some that are leaders in their fields. Northern Germany, particularly Hamburg and Schleswig-Holstein, has become an increasingly attractive […]
Science & Translation BlueHealthTech alliance yields results
Innovative health technologies from the sea are taking shape in the Kiel region. In order to transfer knowledge from marine research into medical applications, the BlueHealthTech innovation alliance brings together regional partners from science, healthcare and business. One of many impressive examples is the company osteolabs, which aims to enable life-saving early diagnoses for numerous diseases.
A major boost for biopharma manufacturing in the North
Biopharmaceuticals made in Schleswig-Holstein: In this interview, Richter BioLogics CEO Kai Pohlmeyer explains why the contract manufacturer has invested 100 million euros in the expansion of its plant in Bovenau and what this means for the Cluster Life Science Nord.
Business Nord|Innovation|Science & Translation HIV gene-editing therapy heads to the clinic
Provirex’ innovative genome editing therapy enables the elimination of persistent viral genomes from infected cells. The start-up is building a therapy hub in the future Science City Hamburg Bahrenfeld.
Science & Translation Gene and Cell Therapies: Shaping the National Strategy
The recently published National Strategy for Gene and Cell-Based Therapies is intended to link the players in this innovative field of medicine throughout Germany and to speed up the introduction of treatment approaches into clinical care. Four experts from Hamburg were involved in the development of the strategy. What is most important to them?
Science & Translation Stem cell medicine in the North: The report
When the experts meet in Hamburg in July for the most important global congress in stem cell research – the ISSCR Annual Meeting – many regional players from the Life Science Nord cluster will also be there. A guide to the region's major players in research and industry in the stem cell field.
Popular
Business Nord Pharmaceutical Production in the North: An Overview
Northern Germany is home to renowned pharmaceutical manufacturers with a global reach. This region is a hub for key industry players involved in pharmaceutical production, ranging from innovative small and medium-sized enterprises to multinational corporations. There are some that are leaders in their fields. Northern Germany, particularly Hamburg and Schleswig-Holstein, has become an increasingly attractive […]
Science & Translation BlueHealthTech alliance yields results
Innovative health technologies from the sea are taking shape in the Kiel region. In order to transfer knowledge from marine research into medical applications, the BlueHealthTech innovation alliance brings together regional partners from science, healthcare and business. One of many impressive examples is the company osteolabs, which aims to enable life-saving early diagnoses for numerous diseases.
A major boost for biopharma manufacturing in the North
Biopharmaceuticals made in Schleswig-Holstein: In this interview, Richter BioLogics CEO Kai Pohlmeyer explains why the contract manufacturer has invested 100 million euros in the expansion of its plant in Bovenau and what this means for the Cluster Life Science Nord.
Business Nord|Innovation|Science & Translation HIV gene-editing therapy heads to the clinic
Provirex’ innovative genome editing therapy enables the elimination of persistent viral genomes from infected cells. The start-up is building a therapy hub in the future Science City Hamburg Bahrenfeld.